Most Recent Announcements
July 18, 2022
Boston University, Evidation publish study on voice as a digital marker in detection of Alzheimer’s Disease
Evidation researchers, alongside researchers at Boston University School of Medicine, have announced the publication of study results that examine the use of voice recordings and transcripts as potential diagnostic tools for Alzheimer's Disease.
April 4, 2022
Digital Medicine Society, Evidation, and Industry Partners Launch Toolkit to Support Reimbursement for New Drugs Developed Using Digital Endpoints
Today, the Digital Medicine Society (DiMe), in partnership with Evidation, Anthem, Biogen, Eli Lilly, Janssen, Merck, Pfizer, and Savvy Co-op, announced the public launch of the 3Ps of Digital Endpoint Value (3Ps), a toolkit of resources created to facilitate the inclusion of digital endpoints as evidence for payers in reimbursement decisions for new drugs.
March 15, 2022
Evidation, VA Collaborate to Enroll Veterans in Personalized Heart Health Program
Evidation and the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) announced today an initiative to enroll Veterans in Heart Health on Evidation—a specialized heart health program built on the Evidation app that encourages individuals to understand and engage with their cardiovascular health from anywhere, using their smartphones and wearable devices.
December 2, 2021
Michael J. Fox Foundation Partners with Evidation to Expand Parkinson’s Progression Markers Initiative to Enroll 100,000 Participants Online
Evidation and The Michael J. Fox Foundation announce a partnership in expanding the Parkinson's Progression Markers Initiative to enroll 100,000 more participants.
September 20, 2021
Evidation Study Shows Digital Intervention Increases Flu Vaccination Rates Among People With Diabetes
Evidation's study, published in npj Digital Medicine, shows people with diabetes who received digital content via Evidation’s mobile app platform were more likely to get vaccinated.
July 22, 2021
Evidation Collaborates with Merck on Digital Monitoring Study for Alzheimer's Disease
Evidation announces a collaboration with Merck to detect and monitor the treatment of Alzheimer's Disease.
July 22, 2021
Outsourcing Pharma: Merck, Evidation join forces on Alzheimer’s data solutions
Evidation and Merck have announced a collaboration geared toward investigating the usefulness of remotely collected digital measures, in order to detect and monitor Alzheimer’s. The work is centered on the identification of Alzheimer’s digital endpoints that can be collected remotely to accelerate drug development.
April 22, 2021
Bloomberg: Health Data Startup Raises $153 Million to Expand Offerings
Evidation Health raised $153 million in venture capital to expand its digital offerings that are designed to help people improve their own health while providing fodder for medical research.
May 7, 2020
Axios: Coping with the pandemic's hidden mental health toll
Evidation just announced a nationwide study with New York City Department of Health and Mental Hygiene and Mount Sinai's Icahn School of Medicine to understand the mental health impact of the pandemic. "This is typically a hidden burden for most people," said Ernesto Ramirez, design lead for research and analytics and learning at Evidation. "The waterfall of that burden doesn't come until much later, especially now that people have less access to mental health services they usually access."
February 26, 2020
Fierce: Apple, Johnson & Johnson team up on heart study using Apple Watches
Johnson & Johnson is partnering with Apple to study atrial fibrillation and how wearable technologies can help people identify afib to reduce the likelihood of an adverse health outcome. Health technology company Evidation Health is also a collaborator on the study, providing the technology and operations that enable the Heartline Study app and study experience for participants.
August 7, 2019
CNBC: Apple and Eli Lilly are studying whether data from iPhones and Apple Watches can detect signs of dementia
“With this research, we looked at how everyday behavior data, such as those captured by iPhones, Apple Watches, and Beddit sleep monitors, may be effective in differentiating between individuals with mild cognitive impairment and early Alzheimer’s disease, and those without symptoms,” Evidation co-founder Christine Lemke told CNBC.